Shoulder Innovations, Inc.

SI Healthcare Medical Devices

Shoulder Innovations, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $47.3 million, up 49.6% from fiscal 2024.

Revenue
+37.7%
EPS
+46.9%
Free cash flow
+38.6%
Total debt
0.00%

Quarter to September 2026, against a year earlier

20.29 0.08 −0.39%
Market cap
$424.1M
P/E
0.0×
Fwd P/E
−10.2×
Dividend yield
—
F-score
n/a
Altman Z
2.53
Beneish M
−2.42
Dividend safety
n/a
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+6 more quarters

P/S ratio
6.11 7.00 5.57 2.62
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(61.63) (56.89) (24.28) (14.12)
P/B ratio
3.33 3.38 2.26 0.88
EV/Sales
4.91 5.60 3.83 0.31
EV/EBITDA
0.00 0.00 0.00 0.00
EV/FCF
(7.41) (7.14) (4.72) (0.41)
Current Ratio
10.68 10.71 11.81 11.07
Net Debt/EBITDA
12.02 9.51 12.01 14.67
Debt/Equity
0.13 0.12 0.11 0.11
Earnings Yield
(8.57%) (9.47%) (1,149.07%) (1,529.23%)
Free Cash Flow Yield
(10.83%) (11.19%) (14.59%) (29.04%)
Free Cash Flow per Share
(0.33) (0.46) (0.73) (1.28)
Book value per Share
5.68 6.00 6.44 16.23
Free Cash Flow
(6.98) (9.55) (15.09) (11.06)
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026